In this study, we investigated the effects of mutant CRP F66A/T76Y/E81A, capable of binding to atherogenic LDL but incapable of binding to PCh, on the development of atherosclerosis in male ldlr−/− mice. The gene discussed is LDLR; the disease is atherosclerosis.